Conference abstract · 26 Oct 2022
Conference abstractPublished 29 Aug 2016
Artemisia : from therapy to prophylaxis
Scientist, IFBV-BELHERB, Luxembourg
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Since 9 years, the association IFBV-BELHERB from Luxembourg has established a working relationship with African and South American universities, in close cooperation with other European research institutions. Several of these partners have run clinical trials with Artemisia annua tea. In all these trials a therapeutical effect of 95 % or higher was confirmed by the use over 7 days of whole leaf infusion, capsules or tablets. One of the surprising effects noticed in these trials was that that the artemisinin content had very little impact on the results. This lead us to make an analysis as complete as possible of all the constituents, organic and inorganic, in a large series of A. annua samples from different origins. A. annua from Luxembourg which had shown very promising antimalarial results, excellent bactericidal properties and a strong anti-inflammatory effect contained very little artemisinin but higher concentrations of certain essential oils. The effect of water soluble polysaccharides, amino acids, phytosterols and saponins has been neglected in the past because most of the A. annua extracts had been obtained with organic solvents. Several papers have shown that A. annua ingested as powdered leaves or in conjunction with fatty food significantly increases the artemisinin concentration in the blood. It is well documented in the literature that A. afra or sieberi which contain little or no artemisinin are extensively used as antimalarials. They contain at least 5 molecules of the same antimalarial efficacy as artemisinin. Recent double blind randomized clinical trials with 1000 patients in RD Congo show that Artemisia afra is equivalent to A. annua and has a higher efficiency than ACTs. More recent research from the Al Quds University has shown that aqueous infusions of several Artemisia species strongly inhibit beta-hematin, like chloroquine did. But the most important finding in several of the clinical trials, especially in Kenya and Uganda, was that people who drink one or two cups of A. annua tea per week become immune against malaria. Similar strong prophylactic results have been obtained with ARTAVOL, a mixture of herbs developed by the Ministry of Health in Uganda, mixture containing Artemisia without artemisinin. Resistance in this case is not related to the killing power of one single molecule like artemisinin but to the polytherapy of the whole plant which not only eliminates the parasites but boosts the immune system, avoiding thus infection, reinfection or recrudescence.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 6 Jan 2022
Rules of the Therapy and Prophylaxis
Conference abstract · 27 Nov 2020
Liver toxicity induced by an isoniazid prophylaxis therapy in an hiv infected single women in namakkal: a case reports
Research article · 22 Jun 2020
Convalescent Plasma Therapy for Prophylaxis and Treatment of COVID-19: A Systematic Research of Facts and Files, A Narrative Review
Research article · 31 May 2019
Comparing Ficus vogelii leaf extract and omeprazole as therapy and prophylaxis for aspirin-induced gastric ulcer in wistar rat.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Pierre Lutgen”
